Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban

Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban

Background: Atrial fibrillation (AF) is the most common arrhythmia associated with high risk of venous thromboembolism. Inflammatory mechanisms may be involved in the pathophysiology of AF and in the AF-related thrombogenesis, and patients with AF might benefit from the use of anticoagulants with an...

Full description

Bibliographic Details
Main Authors: Gabriela Lopes Martins, Rita Carolina Figueiredo Duarte, Érica Leandro Marciano Vieira, Natalia Pessoa Rocha, Estêvão Lanna Figueiredo, Francisco Rezende Silveira, José Raymundo Sollero Caiaffa, Rodrigo Pinheiro Lanna, Maria das Graças Carvalho, András Palotás, Cláudia Natália Ferreira, Helton José Reis
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
inflammation
warfarin
rivaroxaban
cytokines
chemokines
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2020.00114/full

Internet

https://www.frontiersin.org/article/10.3389/fcvm.2020.00114/full

Similar Items